Olaparib Boosts Survival for Women With Advanced Ovarian Cancer

THURSDAY, March 25, 2021 -- Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called " maintenance therapy " with a targeted cancer...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news